Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$12.70 and traded as high as C$13.17. Cipher Pharmaceuticals shares last traded at C$12.65, with a volume of 11,651 shares.
Cipher Pharmaceuticals Stock Down 3.3 %
The company has a current ratio of 2.00, a quick ratio of 2.67 and a debt-to-equity ratio of 41.22. The firm has a market cap of C$219.39 million, a price-to-earnings ratio of 13.50 and a beta of 1.20. The firm’s 50 day simple moving average is C$12.64 and its two-hundred day simple moving average is C$14.15.
Insider Activity
In related news, Director Harold Morton Wolkin sold 3,500 shares of the firm’s stock in a transaction on Monday, March 24th. The stock was sold at an average price of C$13.49, for a total value of C$47,215.00. 42.00% of the stock is owned by company insiders.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.
See Also
- Five stocks we like better than Cipher Pharmaceuticals
- The 3 Best Blue-Chip Stocks to Buy Now
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Choose Top Rated Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 3 Fintech Stocks With Good 2021 Prospects
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.